Evidence map›Paper›PMID 29414873›Full record

ArticleNanomaterials (Basel, Switzerland)2018

Hexosomes with Undecylenic Acid Efficient against Candida albicans.

Marijana Mionić Ebersold, Milica Petrović, Wye-Khay Fong, Debora Bonvin, Heinrich Hofmann, Irena Milošević

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Novel Formulation of Undecylenic Acid induces Tumor Cell Apoptosis.International journal of molecular sciences · 2022
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Synergistic Effect of Quinic Acid Derived FromFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Marijana Mionić EbersoldPowder Technology Laboratory, Institute of Materials, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland. marijanamionic@gmail.com.ORCID 0000-0003-0142-1539
Milica PetrovićPowder Technology Laboratory, Institute of Materials, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland. petrovicmilica21@gmail.com.
Wye-Khay FongAdolphe Merkle Institute, University of Fribourg, 1700 Fribourg, Switzerland. khay.fong@unifr.ch.
Debora BonvinPowder Technology Laboratory, Institute of Materials, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland. debora.bonvin@gmail.com.ORCID 0000-0002-3059-3623
Heinrich HofmannPowder Technology Laboratory, Institute of Materials, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland. heinrich.hofmann@epfl.ch.
Irena MiloševićPowder Technology Laboratory, Institute of Materials, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland. irena.markovic@epfl.ch.ORCID 0000-0001-5099-0207
École Polytechnique Fédérale de Lausanne · CHUniversity of Fribourg · CHUniversity of Nis · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the growing issues with fungal infections, especially with

Indexed as

anti-CandidaantifungalCandida albicansfungicidalhexosomelipid-based liquid crystalundecylenic acid

Identifiers

PMID29414873
PMCPMC5853723
OpenAlexW2791825252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.